Sanofi’s venglustat bombs again, but isn’t dead yetShortly after failing a Parkinson’s disease study, Sanofi’s venglustat has missed the mark in another trial in autosomal Share XSanofi’s venglustat bombs again, but isn’t dead yethttps://pharmaphorum.com/news/sanofis-venglustat-bombs-again-but-isnt-dead-yet/
